Long-term follow-up study of bioactive bone cement in canine total hip arthroplasty

J Long Term Eff Med Implants. 2006;16(4):291-9. doi: 10.1615/jlongtermeffmedimplants.v16.i4.30.

Abstract

We report a long-term study of bioactive bone cement (BABC) in a canine total hip arthroplasty (THA) at follow-up of 8 years. Previous studies have shown excellent biomechanical and histological results at follow-up of 6, 12, and 24 months. In the present study, THA was performed in a beagle dog using BABC consisting of an apatite- and wollastonite-containing glass ceramic (AW-GC) powder and SiO2 powder as the filler and a bisphenol-a-glycidyl methacrylate (Bis-GMA) based resin as the organic matrix. Histological examination showed direct bonding between BABC and bone without any intervening soft tissue layer at the BABC-bone interface. A reactive layer, through which BABC bonded to the bone, was observed thicker at 8 years than it was at 24 weeks. No adverse effects of BABC were observed. BABC maintained the high bioactivity and direct bonding to bone in a canine THA at follow-up of 8 years.

MeSH terms

  • Animals
  • Apatites
  • Arthroplasty, Replacement, Hip*
  • Biocompatible Materials
  • Bisphenol A-Glycidyl Methacrylate
  • Bone Cements / chemistry
  • Bone Cements / therapeutic use*
  • Cementation
  • Ceramics
  • Dogs
  • Femur / diagnostic imaging
  • Femur / ultrastructure
  • Follow-Up Studies
  • Microscopy, Electron, Scanning
  • Radiography
  • Silicic Acid

Substances

  • Apatites
  • Biocompatible Materials
  • Bone Cements
  • apatite-wollastonite-containing glass ceramic
  • Silicic Acid
  • Bisphenol A-Glycidyl Methacrylate